Book Cover
Home  |   Healthcare   |  Metagenomics Market

Metagenomics Market Size, Share, Growth, and Industry Analysis, By Type (Sequencing and Data Analytics Services, Kits and Reagents, Other), By Application (Human Health, Environmental, Other), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Metagenomics Market Overview

The global Metagenomics Market is predicted to progress from USD 1207.4 Million in 2026 to USD 5057.96 Million by 2035, registering a CAGR of 17.25% through 2026-2035.

The Metagenomics Market is experiencing substantial growth as next-generation sequencing technologies, microbiome research, and advanced bioinformatics expand across healthcare, environmental monitoring, and biotechnology. Sequencing and Data Analytics Services represent approximately 52% of market activity, supported by growing demand for microbial identification, genome characterization, and computational analysis. Metagenomics enables researchers to examine genetic material directly from complex biological samples without requiring conventional microbial cultivation. Increasing adoption of high-throughput sequencing, automated sample preparation, and artificial intelligence-based interpretation is improving research efficiency. 

The United States Metagenomics Market benefits from established genomic research infrastructure, extensive academic collaboration, biotechnology innovation, and growing adoption of sequencing-based analysis. North America accounts for approximately 39% of global metagenomics activity, with the United States representing the principal regional research and technology center. Universities, biotechnology organizations, clinical laboratories, and environmental institutions increasingly use metagenomic technologies for microbial characterization and research investigations. Illumina, Thermo Fisher Scientific, Qiagen NV, and Pacific Biosciences of California maintain important capabilities across sequencing, analytical technologies, and laboratory sample preparation. 

Global Metagenomics Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Expanding microbiome research and infectious disease investigations support metagenomics adoption, with approximately 64% of market development activity associated with sequencing automation, microbial genome analysis, and advanced laboratory capabilities.
  • Major Market Restraint: High sample preparation costs and complex laboratory requirements restrict broader adoption, with approximately 41% of experimental expenditure associated with DNA extraction and sequencing library preparation activities.
  • Emerging Trends: Artificial intelligence and machine learning are transforming metagenomic data analysis, with approximately 62% of research institutions in the report's assessment incorporating AI-supported technologies for microbial identification and complex genomic dataset interpretation.
  • Regional Leadership: North America dominates the Metagenomics Market with approximately 39% share, supported by advanced genomic research infrastructure, established biotechnology companies, extensive academic collaboration, and growing adoption of sequencing technologies.
  • Competitive Landscape: Illumina maintains a leading competitive position in metagenomic sequencing with an approximately 28% reported market share, supported by high-throughput sequencing technologies, advanced analytical platforms, and extensive genomic research capabilities.
  • Market Segmentation: Sequencing and Data Analytics Services lead product segmentation with approximately 52% market share, supported by growing demand for microbial genome characterization, computational analysis, and integrated sequencing services across research laboratories.
  • Recent Development: Qiagen NV showcased its QIAsprint Connect automated sample preparation system in 2026, offering high-throughput laboratory processing while reducing plastic consumption by up to 50%, supporting improved workflow efficiency and sustainable genomic research operations.

The Metagenomics Market is witnessing increasing adoption of high-throughput sequencing, portable analytical systems, and integrated bioinformatics platforms. Approximately 47% of sequencing facilities examined in earlier industry research incorporated hybrid sequencing approaches combining short-read and long-read technologies. These methods support microbial diversity analysis, taxonomic classification, and improved characterization of complex biological samples. Long-read sequencing is particularly valuable for examining microbial genome structures and identifying genetic relationships that may be difficult to resolve using shorter sequencing fragments. Cloud-based computational platforms are also gaining importance as research organizations manage expanding genomic datasets. 

Artificial intelligence and machine learning are becoming important components of metagenomic data interpretation. Approximately 62% of research institutions in the referenced industry assessment incorporated AI-supported analytical approaches for microbial identification and complex dataset processing. Researchers increasingly require tools capable of recognizing microbial populations, comparing genetic sequences, and identifying functional characteristics within diverse biological communities. Portable sequencing technologies are also expanding opportunities for environmental monitoring and field-based investigations. Oxford Nanopore Technologies Ltd. maintains relevant capabilities through real-time sequencing platforms, while Pacific Biosciences of California provides long-read technologies supporting microbial genome characterization. 

Market Dynamics

Driver

"Expanding microbiome research and sequencing adoption accelerate market development."

Growing demand for microbial characterization and infectious disease research remains a major driver of the Metagenomics Market. Approximately 41% of global research activity focuses on Human Health applications, highlighting the importance of microbiome analysis in modern biological investigations. Metagenomic sequencing enables researchers to examine microbial genetic material without depending entirely on cultivation methods. This capability supports investigations involving complex microbial communities, antibiotic resistance, and microbial interactions with human biological systems. Academic institutions and biotechnology organizations increasingly use these technologies to study relationships between microbiome composition and health conditions. 

Technological improvements provide additional momentum by increasing sequencing capacity and laboratory efficiency. Approximately 64% of market development activity in the underlying assessment is associated with sequencing automation and microbial genome analysis. Automated workflows can reduce manual handling, strengthen sample tracking, and support consistent laboratory operations. Illumina, BGI Group, Novogene Co. Ltd., and Thermo Fisher Scientific maintain relevant technologies and services supporting genomic research. 

Restraint

"High laboratory processing costs restrict broader adoption of metagenomic technologies."

High sample preparation expenses and specialized infrastructure requirements remain important restraints in the Metagenomics Market. Approximately 41% of experimental expenditure in the underlying industry assessment is associated with sample extraction and library preparation activities. Metagenomic workflows often require carefully controlled sample collection, DNA isolation, sequencing library preparation, and computational analysis. Processing complex biological materials can involve additional quality control steps to limit contamination and ensure suitable sequencing performance. Smaller laboratories may face financial difficulties when purchasing advanced sequencing equipment or maintaining extensive computational infrastructure. 

Bioinformatics expertise represents another significant barrier because microbial datasets require specialized interpretation and quality assurance. Approximately 34% of smaller laboratories in earlier industry findings reported difficulties maintaining appropriate computational biology capabilities. Metagenomic sequencing generates complex information containing microbial sequences, host-associated genetic material, and potentially ambiguous classifications. Researchers must apply suitable analytical pipelines to distinguish meaningful biological findings from technical contamination or processing artifacts. 

Opportunity

"Environmental microbiome research creates substantial opportunities for sequencing innovation."

Expanding environmental microbiome investigations create important opportunities for metagenomics technology providers. Environmental applications represent approximately 37% of global metagenomics research activity, supported by growing interest in soil ecology, water quality, wastewater monitoring, and microbial biodiversity. Researchers use sequencing technologies to identify microbial communities and investigate their functions within natural and managed environments. Environmental monitoring programs increasingly require analytical methods capable of characterizing complex biological samples without extensive cultivation procedures. 

Advanced sequencing services offer additional opportunities as environmental research projects become more complex. Earlier industry assessments recorded approximately 24% growth in soil and water metagenomics initiatives during a recent reporting period. Service providers can differentiate through sample handling expertise, dependable sequencing quality, and interpretation of diverse microbial datasets. Long-read technologies can support microbial genome reconstruction and improve characterization of biological populations within mixed samples. 

Challenge

"Complex genomic datasets and inconsistent workflows challenge analytical reliability."

Managing large sequencing datasets remains an important challenge in the Metagenomics Market. Individual research projects can generate multiple terabytes of information, while approximately 39% of laboratories in the underlying assessment reported using standardized quality control protocols. Metagenomic analysis requires substantial data storage, computational processing, and carefully selected reference databases. Biological samples can contain genetically similar organisms that are difficult to distinguish using limited sequencing information. 

Bioinformatics standardization creates further operational challenges as sequencing technologies and analytical software continue evolving. Approximately 44% of research organizations evaluated in earlier industry findings invested in internal computational biology capabilities to manage complex genomic information. Different sequencing platforms generate data with distinct characteristics, requiring appropriate software configurations and processing procedures. Researchers increasingly combine short-read and long-read datasets, creating additional requirements for analytical integration. 

Metagenomics Market Segmentation 

Global Metagenomics Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

Sequencing and Data Analytics Services: Sequencing and Data Analytics Services account for approximately 52% of global Metagenomics Market activity, making this the leading product category. These services include microbial DNA sequencing, taxonomic classification, functional analysis, and computational interpretation of complex biological samples. Universities, biotechnology organizations, healthcare researchers, and environmental institutions increasingly outsource specialized sequencing activities to laboratories with advanced equipment and experienced analytical teams. Service providers support research projects requiring high-throughput processing, microbial diversity analysis, and consistent reporting. Novogene Co. Ltd., BGI Group, Eurofins Scientific, and Macrogen Inc. maintain relevant genomic sequencing or analytical capabilities supporting different research applications.

Kits and Reagents: Kits and Reagents represent approximately 31% of Metagenomics Market demand. This category includes DNA extraction materials, sequencing library preparation reagents, amplification products, purification materials, and other laboratory consumables required for microbial genetic analysis. Reliable reagent performance is important because sample preparation can influence the diversity and quality of recovered microbial DNA. Laboratories process biological materials with varying microbial abundance, contamination risks, and extraction characteristics. Qiagen NV, Thermo Fisher Scientific, Merck KGaA, Promega Connections, and Bio-Rad Laboratories Inc. maintain relevant laboratory product capabilities supporting genomic research.

Other: Other products account for approximately 17% of global metagenomics activity. This category includes supporting technologies and specialized solutions outside the principal sequencing services and reagent classifications. Research laboratories may require dedicated analytical software, workflow integration tools, and technical support capabilities to manage complex microbial datasets. Companies providing computational analysis technologies help researchers organize sequencing outputs, compare microbial communities, and examine functional genetic characteristics. Innovation in software compatibility, processing efficiency, and research support can strengthen adoption among institutions operating diverse sequencing platforms.

By Applications

Human Health: Human Health represents approximately 41% of global Metagenomics Market activity, making it the leading application category. Researchers use metagenomics to investigate gut microbial communities, infectious agents, antimicrobial resistance, and interactions between microorganisms and human biological systems. Sequencing-based approaches allow identification of genetic material from complex samples without relying exclusively on traditional cultivation. Academic medical centers, research hospitals, and biotechnology organizations increasingly examine microbiome composition in relation to disease mechanisms and therapeutic development. Human microbiome studies also support investigations involving nutrition, inflammation, and microbial diversity.

Environmental: Environmental applications account for approximately 37% of the global Metagenomics Market. Researchers use sequencing technologies to investigate microbial communities in soil, freshwater, marine environments, wastewater, and other ecological systems. Metagenomic analysis supports biodiversity assessment, environmental monitoring, and examination of microbial functions within natural ecosystems. Scientific organizations increasingly use microbial sequencing to investigate environmental changes and interactions between microorganisms and ecological conditions. Specialized preparation procedures are required because environmental samples frequently contain complex materials that can interfere with DNA recovery and analysis.

Other: Other applications represent approximately 22% of global metagenomics activity. This category includes additional specialized biological investigations outside the principal Human Health and Environmental classifications. Researchers use metagenomic technologies to examine microbial functions, genetic diversity, and biological processes relevant to scientific discovery. Sequencing enables identification of genetic sequences associated with microbial metabolic pathways and other biological characteristics. Specialized analytical services support organizations requiring advanced genomic research capabilities.Continued development of advanced sequencing platforms and computational tools supports the expansion of specialized metagenomics applications.

Regional Outlook

Global Metagenomics Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America leads the global Metagenomics Market with approximately 39% share, supported by established genomic research institutions, biotechnology companies, advanced clinical laboratories, and extensive scientific collaboration. The United States remains the leading regional center for sequencing technology development and microbiome research. Universities and research organizations increasingly investigate microbial communities associated with human health, infectious diseases, and environmental systems. The presence of major sequencing technology providers strengthens access to advanced equipment and specialized analytical services. Growing adoption of automated workflows and integrated bioinformatics supports continued expansion.

Europe

Europe accounts for approximately 27% of the Metagenomics Market, supported by advanced genomic research capabilities, established universities, and growing microbiome-related investigations. Germany, the United Kingdom, and France represent important research centers with specialized sequencing laboratories and bioinformatics expertise. European institutions increasingly use metagenomics for Human Health and Environmental investigations, including microbial ecology, infectious disease research, and environmental surveillance. Growing interest in standardized analytical procedures is encouraging collaboration across research organizations. Advanced sequencing instruments and integrated computational technologies support regional laboratory operations.

Asia-Pacific

Asia-Pacific represents approximately 25% of global Metagenomics Market activity, supported by expanding genomic research infrastructure, biotechnology development, and increasing scientific investment. China, Japan, India, and South Korea maintain important research institutions and commercial sequencing capabilities. Regional organizations increasingly use metagenomic technologies for Human Health investigations and Environmental research. Established sequencing service providers and growing laboratory automation capabilities support access to advanced genomic analysis. Increasing collaboration between universities, biotechnology companies, and research laboratories is strengthening regional market opportunities.

Middle East and Africa

Middle East and Africa account for approximately 9% of global metagenomics activity, supported by growing investment in biotechnology infrastructure, public health research, and environmental monitoring. The United Arab Emirates, Saudi Arabia, and South Africa represent important regional centers for advanced laboratory development. Metagenomic sequencing supports microbial characterization, infectious disease investigations, and environmental biodiversity research. Academic partnerships and government-supported scientific initiatives are strengthening regional research capabilities. Access to specialized equipment and trained computational specialists remains important for continued adoption.

Rest of the World

Rest of the World includes additional geographic markets, particularly Latin American research environments where genomic sequencing and microbiome investigations are developing. The global market covers 3 principal application categories, creating opportunities for institutions with varied biological research requirements. Universities, environmental organizations, and biotechnology laboratories increasingly examine microbial populations using sequencing-based techniques. Demand depends on access to reliable laboratory equipment, suitable reagents, and computational analysis capabilities. Collaborative research projects help institutions develop expertise in complex genomic technologies.

List of Top Metagenomics Market Companies

  • Novogene Co. Ltd
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • IntegraGen SA
  • BGI Group
  • Illumina
  • SciGenom Labs
  • Agilent Technologies
  • Qiagen NV
  • Enterome Bioscience
  • Eurofins Scientific
  • Pacific Biosciences of California
  • Aperiomics
  • Macrogen Inc.
  • Thermo Fisher Scientific
  • Swift Biosciences
  • Quest Diagnostics
  • Promega Connections
  • DNAstar Inc.
  • GENEWIZ
  • Oxford Nanopore Technologies Ltd.
  • PerkinElmer
  • F.Hoffmann-La Roche
  • The MITRE Corporation

Top Two Companies with Highest Market Share

  • Illumina: Illumina holds approximately 28% of the global metagenomic sequencing market, based on reported 2024 market estimates. The company maintains a prominent competitive position through high-throughput sequencing technologies, advanced analytical platforms, and an extensive genomic research customer network. Its sequencing solutions support microbiome research, microbial identification, human genomics, and complex biological investigations.
  • Thermo Fisher Scientific: Thermo Fisher Scientific holds approximately 18% of the global metagenomic sequencing market, based on reported 2024 market estimates. The company maintains a strong competitive presence through sequencing technologies, laboratory reagents, sample preparation systems, and integrated analytical solutions. Its genomic technologies support microbial investigations, infectious disease research, and specialized metagenomics applications.

Investment Analysis and Opportunities

Investment opportunities in the Metagenomics Market increasingly focus on sequencing automation, bioinformatics infrastructure, microbiome research, and integrated laboratory technologies. Approximately 44% of investment activity in the underlying assessment concentrated on automation and computational analysis capabilities. Research institutions require scalable sequencing systems capable of processing complex biological samples while maintaining reliable analytical results. Advanced data processing infrastructure is becoming increasingly important as microbial research projects generate substantial genomic information. Companies providing automated extraction systems, high-throughput sequencing technologies, and integrated bioinformatics services can address growing demand. Investments in technical training and workflow standardization also support research accessibility.

Environmental sequencing and Human Health research provide additional opportunities for technology developers and service providers. Approximately 38% of research funding activity in the referenced market assessment involved government-supported microbiome initiatives. Biotechnology organizations increasingly investigate microbial diversity and biological interactions using advanced sequencing technologies. Service providers capable of delivering sample processing, data analysis, and research interpretation can strengthen their competitive positioning. Continued investment in laboratory infrastructure, computational expertise, and sequencing technology development is expected to support commercial expansion.

New Product Development

New product development in the Metagenomics Market increasingly emphasizes high-throughput sequencing, automated sample preparation, long-read technologies, and improved analytical accuracy. Approximately 19% of selected reagent development activity focused on improving recovery performance for challenging biological samples. Manufacturers are introducing laboratory solutions designed to reduce manual handling, improve sequencing consistency, and support complex microbiome investigations. Advanced extraction materials help laboratories process samples containing low microbial abundance or substances that interfere with genomic analysis. Illumina, Qiagen NV, Thermo Fisher Scientific, and Pacific Biosciences of California maintain relevant technology portfolios supporting sequencing and laboratory workflow development.

Integrated computational platforms represent another important product innovation area. Approximately 27% improvement in processing turnaround was associated with selected integrated sequencing and analytical workflows in earlier assessments. Manufacturers increasingly combine sequencing technologies with automated interpretation, data management, and quality control capabilities. Long-read sequencing platforms support microbial genome reconstruction, while advanced bioinformatics tools enable more detailed biological analysis. Product development will continue emphasizing reliable results, improved sample compatibility, and efficient laboratory operations.

Five Recent Developments

  • February 2026 – QIAGEN Introduces Advanced Automated Sample Preparation Platform: Qiagen NV showcased its QIAsprint Connect high-throughput automation system, capable of processing up to 192 samples per run. The platform also reduces plastic consumption by up to 50%, supporting more efficient laboratory workflows and sustainable genomic sample preparation.
  • March 2026 – PacBio Expands Large-Scale Environmental Metagenomics Sequencing: Pacific Biosciences of California announced its collaboration with Basecamp Research to support the Trillion Gene Atlas initiative using Revio HiFi sequencing technology. The project targets approximately 100,000 biological samples collected across multiple geographic regions to advance microbial genome discovery.
  • April 2026 – Novogene Launches Advanced Single-Cell Sequencing Services: Novogene Co. Ltd introduced its Illumina Single-Cell 3' RNA Sequencing Service, integrating optimized sample preparation, sequencing, and bioinformatics analysis. The development expands its genomic research service portfolio and supports detailed molecular characterization across complex biological research applications.
  • April 2026 – Oxford Nanopore Advances Environmental Microbial Genome Analysis: Oxford Nanopore Technologies Ltd released a compost metagenomics dataset generated using 1.45 terabases of sequencing data. The analysis reconstructed 5,598 metagenome-assembled genomes, demonstrating the potential of long-read sequencing for investigating complex environmental microbial communities.
  • September 2026 – BGI Group Introduces Advanced Multiomics Research Technologies: BGI Group presented new genomic and multiomics technologies during its global product launch event, marking its 27th anniversary. The developments emphasized artificial intelligence integration, advanced biological analysis, precision health research, and environmental applications.

Future Outlook

The Metagenomics Market is expected to experience sustained growth as genomic sequencing technologies, microbiome research, and advanced computational analysis become increasingly important across biological research. Expanding applications across Human Health, Environmental, and Other investigations will create opportunities for sequencing service providers, laboratory technology manufacturers, and bioinformatics developers. Companies will increasingly focus on advanced sample preparation, automated sequencing workflows, portable analysis platforms, and improved microbial identification technologies. Growing interest in microbiome-associated biological research, infectious disease investigations, and environmental monitoring will encourage continued investment in laboratory infrastructure and scientific innovation. 

North America is expected to maintain a leading position in the Metagenomics Market through established biotechnology infrastructure, academic collaboration, and advanced sequencing capabilities. Europe and Asia-Pacific will continue expanding genomic research activities through laboratory modernization, environmental investigations, and scientific investment. Middle East and Africa and other developing research markets will provide opportunities through improved access to sequencing technologies and specialized analytical services. 

Metagenomics Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 1207.4 Million in 2026

Market Size Value By

USD 5057.96 Million by 2035

Growth Rate

CAGR of 17.25% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Sequencing and Data Analytics Services
  • Kits and Reagents
  • Other

By Application :

  • Human Health
  • Environmental
  • Other

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Metagenomics Market is expected to reach USD 5057.96 Million by 2035.

The Metagenomics Market is expected to exhibit a CAGR of 17.25% by 2035.

Novogene Co. Ltd, Bio-Rad Laboratories Inc., Merck KGaA, IntegraGen SA, BGI Group, Illumina, SciGenom Labs, Agilent Technologies, Qiagen NV, Enterome Bioscience, Eurofins Scientific, Pacific Biosciences of California, Aperiomics, Macrogen Inc., Thermo Fisher Scientific, Swift Biosciences, Quest Diagnostics, Promega Connections, DNAstar Inc., GENEWIZ, Oxford Nanopore Technologies Ltd., PerkinElmer, F.Hoffmann-La Roche, The MITRE Corporation

In 2026, the Metagenomics Market value will reach at USD 1207.4 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified